Cerritos Reference Laboratories INC

Cerritos Reference Laboratories INC was paid $1.68M by Medicaid between Jan 2018 and Nov 2023, across 27 billing codes. Its largest line is U0004, 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r — 30% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in California

Rank by total paid#154 of 561

Median peer was paid$222K

This provider vs. median7.6×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	28,573	$650K
2019	16	$0.00
2022	5,068	$201K
2023	18,659	$826K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	30%	8,240	3,332	$507K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	25%	9,240	3,603	$413K
87806		11%	7,148	3,581	$186K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	11%	6,006	6,002	$186K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	11%	5,960	5,957	$184K
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	6.2%	6,138	2,586	$104K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	2.2%	1,832	1,832	$37K
86592		1.1%	5,013	5,010	$19K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	381	378	$16K
80055		<1%	374	374	$11K
84702		<1%	302	302	$3K
87811	Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19)	<1%	96	84	$3K

15 more codes

85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	435	$2K
86780		<1%	171	$2K
84443	Thyroid stimulating hormone (TSH)	<1%	139	$1K
80053	Comprehensive metabolic panel	<1%	222	$1K
80061	Lipid panel	<1%	173	$1K
82950		<1%	94	$354.38
81001		<1%	137	$283.20
83036	Hemoglobin; glycosylated (A1C)	<1%	90	$269.15
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	13	$152.51
99000		<1%	43	$140.61
87081		<1%	12	$61.32
82248		<1%	17	$40.56
85014		<1%	12	$25.80
85018		<1%	12	$24.84
36415	Collection of venous blood by venipuncture	0%	16	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialKHAN, HANIYA (OWNER)